Navigation Links
Stanley to Acquire Oberon Associates
Date:6/26/2008

s annual revenue will meet or exceed Stanley's annual organic growth goals of 10 to 15 percent and that the transaction will be accretive to its fiscal year 2009 earnings.

"We are looking forward to welcoming Oberon to Stanley," said Phil Nolan, Stanley's chairman, president and CEO. "This transaction is consistent with Stanley's growth strategy that calls for the development of new customers, contract vehicles and service offerings via mergers and acquisitions. In addition, it reinforces Stanley's strategy of expanding our presence in key markets positively impacted by the Base Realignment and Closure process. Oberon complements our commitment to delivering the highest quality of support for our customers' mission-essential programs and fostering an employee- focused culture. We also believe this acquisition will provide meaningful cross-selling opportunities as we seek to continue our strong record of organic growth."

"We are excited about the opportunity to bring a new, but complementary, set of customers and technical expertise to Stanley," said Jodi L. Johnson and David L. Young, co-founders of Oberon. "We are also very optimistic that the transition will be a smooth one because of our similar cultures and a mutual urgency to ensure customer satisfaction."

KippsDeSanto & Co. is acting as exclusive financial advisor to Oberon in this transaction.

Stanley management will conduct a conference call today at 5:00 pm EDT to discuss the Oberon transaction. To obtain the dial-in number, please contact Rashida Gofney at (703) 310-3209. The conference call will be broadcast simultaneously on the Investor Relations page of Stanley's website, http://www.stanleyassociates.com. Investors are advised to log on to the website at least 15 minutes prior to the call to register, download and install any necessary audio software. An archive of the webcast will be available for one week followi
'/>"/>

SOURCE Stanley, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology news :

1. Stanley to Acquire Oberon Associates
2. Study finds environmental tests help predict hospital-acquired Legionnaires disease risk
3. bioMETRX, Inc. Acquires Patent for Biometric Padlock
4. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
5. bioMETRX, Inc. Acquires Patent for Biometric Padlock
6. Argonne National Lab acquires first SiCortex SC5832
7. Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network
8. Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network
9. Biotech Co. founded by UCLA Scientists to be acquired by Astellas, Pharma Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... social snubbing? Your genetics, not your friends, may be at ... opioids, relieve not only physical pain, but also some forms ... of 1000 Biology member Markus Heilig shows that small genetic ... the intensity of people,s responses to social rejection. , ...
(Date:12/3/2009)... of scientists from the U.S. Department of Energy,s (DOE) ... of Science has made a major step in understanding ... is necessary to carry out important biological processes. The ... Nature Structural & Molecular Biology , confirms that ...
(Date:12/2/2009)... results strengthen the evidence that people who smoke cigarettes ... risk for developing colorectal cancer, even after adjusting for ... reason not to smoke, or to quit as soon ... M.S., vice president emeritus, epidemiology and surveillance research at ...
Breaking Biology News(10 mins):Grooving down the helix 2Grooving down the helix 3Cigarette smoking increases colorectal cancer risk 2Guided Delivery Systems Inc Successfully Treats First Patient with Mitral Regurgitation 5011 1Guided Delivery Systems Inc Successfully Treats First Patient with Mitral Regurgitation 5011 2Guided Delivery Systems Inc Successfully Treats First Patient with Mitral Regurgitation 5011 3HBV genotype B B3 and C C1 are the major genotypes in Indonesia 3F 57345 1Kendle to Present at UBS Global Life Sciences Conference 14090 1Kendle to Present at UBS Global Life Sciences Conference 14090 2
... from what a runner might take on a jog, ... make life more comfortable for cattle. , A jogger,s ... pedometer are a few of the tools K-State researchers ... routine procedures, castration and dehorning. , Hans Coetzee, assistant ...
... that are embedded in their cell walls. For the ... the plasmodesmata are lifelines, allowing nutrients and genetic instructions ... cues trigger changes in the structure of the tiny ... The genes and molecular pathways of the plant cell ...
... University March 2-3 to discuss engineering solutions to major ... to education and energy. , The summit is in ... http://www.engineeringchallenges.org/ ) issued last year by the National Academy ... will play a critical part in resolving major societal ...
Other Biology News:Veterinarians developing model to help producers, vets make cattle more comfortable 2Veterinarians developing model to help producers, vets make cattle more comfortable 3CSHL researchers identify gene that helps plant cells keep communication channels open 2CSHL researchers identify gene that helps plant cells keep communication channels open 3Duke forum to address global engineering problems 2
(Date:12/2/2009)... announces that a new market research report ... Carbondioxide Incubators - A Global Market Perspective ... Incubators are the most critical equipment used ... applications for providing a controlled environment to ...
(Date:12/2/2009)... demonstration tires made with BioIsoprene technology, a ... the manufacture of synthetic rubber with renewable biomass, made ... will be on display at a lounge in the ... December 21, while the other tire will make appearances ...
(Date:12/2/2009)... Gabon, December 2 , ... and Heritage" , Coinciding ... 2010 the,Gabonese Republic is hosting an international conference ... resources in Africa. The,conference will be attended by ...
(Date:12/2/2009)... 2 Gamida Cell announced today,a feasibility study ... a gene therapy product which combines technology from ... may have potential to,treat inherited anemias such as ... Cell is developing a series of technologies to ...
Breaking Biology Technology:Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Libreville International Conference 2-3 June 2010 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3
... Marketing and Sales; Susan Koppy ... President, Corporate Development, PT. RICHMOND, Calif., July 2 ... the position of,Vice President, Marketing and Sales and Susan Koppy ... and Ms. Koppy will report,to President & Chief Executive Officer ...
... manufactured from bone marrow; SV Life ... LAKE CITY and HAMBURG, Germany, July 2 AlloCure,Inc., ... therapies,for the treatment of acute kidney injury, today announced ... was led by SV Life Sciences with Novo,A/S joining ...
... Aureus Pharma, a leading provider of,knowledge management solutions ... today that the Aureus Pharma 2008 User Symposium ... 24th., This symposium follows last year,s highly ... Aureus, pharmaceutical and biotech customers,from both Europe and ...
Other Biology Technology:Transcept Pharmaceuticals Appoints Key Senior Executives 2Transcept Pharmaceuticals Appoints Key Senior Executives 3Transcept Pharmaceuticals Appoints Key Senior Executives 4AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 2AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 3Aureus Pharma Announces Date of 2008 Annual User Symposium 2